Leucyl aminopeptidase
Leucyl aminopeptidase (LAP), also known as aminopeptidase L or leucine aminopeptidase, is an enzyme that plays a crucial role in protein metabolism. It belongs to the family of aminopeptidases, which are enzymes that catalyze the removal of amino acids from the N-terminus of peptides and proteins. Leucyl aminopeptidase specifically cleaves leucine, but it can also act on other amino acids with large hydrophobic side chains.
Function[edit | edit source]
Leucyl aminopeptidase is involved in the process of protein degradation, where it aids in the recycling of amino acids for the synthesis of new proteins. This enzyme is essential for maintaining the balance of amino acids within the cell and plays a role in various cellular processes, including cell growth, differentiation, and response to stress. LAP is found in a wide range of organisms, from bacteria to humans, indicating its fundamental importance in biology.
Structure[edit | edit source]
The enzyme is typically a homohexamer, meaning it is composed of six identical subunits. Each subunit contains a zinc ion, which is crucial for the enzyme's catalytic activity. The structure of leucyl aminopeptidase allows it to bind substrates efficiently and catalyze the hydrolysis of peptide bonds adjacent to leucine residues.
Clinical Significance[edit | edit source]
Elevated levels of leucyl aminopeptidase have been observed in certain pathological conditions, such as liver diseases and some types of cancer. Therefore, measuring the activity of this enzyme in blood or tissue samples can serve as a biomarker for diagnosing and monitoring these conditions. Additionally, inhibitors of leucyl aminopeptidase are being explored as potential therapeutic agents for diseases where the regulation of protein degradation is disrupted.
Research[edit | edit source]
Research on leucyl aminopeptidase has provided insights into the mechanisms of protein degradation and the regulation of amino acid levels in cells. Studies on the enzyme's structure and function have also contributed to the development of inhibitors that could be used in the treatment of diseases related to protein metabolism disorders.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD